ZTS Zoetis

$76.27 +0.16%

Updated 16 d ago

Healthcare · Pharmaceutical Preparations

Zoetis (ZTS) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $31.5 billion. Shares last traded at $76.27, 50.8% below their 52-week high. Over the past year the stock is down 50.0%. ZTS trades at a price-to-earnings ratio of 12.05, below the Pharmaceutical Preparations median of 17.31. Net profit margin is 27.5%, above the peer median of -8.9%. Revenue grew 2.3% year over year. The shares yield 2.0% in dividends.

Market Cap

$31.5B

Shares Out

413.2M

EPS (TTM)

$12.12

P/E Ratio

6.29

P/S Ratio

3.31

P/B Ratio

10.01

Dividend / Share

$1.56

Dividend Yield

2.05%

52-Week High

$155.11

52-Week Low

$70.50

Volume

105,209

Avg Vol (3m)

281,719.222

Performance

+1.52%

+4.19%

-4.90%

-37.59%

YTD

-39.42%

-49.95%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

50.17

SMA (50)

$75.61

SMA (200)

$103.26

Price vs SMA50

+0.87%

Price vs SMA200

-26.14%

ATR (14)

$2.60

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$9.5B

Net Income

$2.6B

Gross Margin

71.5%

Operating Margin

—

Net Margin

27.5%

Return on Equity

83.1%

Return on Assets

17.4%

Current Ratio

3.08

Debt / Equity

2.87

Revenue Growth (YoY)

+2.3%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$3.08	2026-08-06
Q1 2026	$1.42	2026-05-07
FY 2025	$6.02	2026-02-12
Q3 2025	$4.65	2025-11-04
Q2 2026	$2.97	2026-08-06
Q1 2026	$1.34	2026-05-07

Full earnings history →

Pharmaceutical Preparations peers

ZTS vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 16 d ago

P/E vs peers

12.05 / 17.31 med

-30% discount

P/S vs peers

3.31 / 11.11 med

-70% discount

Net margin vs peers

27.5% / -8.9% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.